(DRW3) Drägerwerk & Co. KGaA - Ratings and Ratios

Drägerwerk AG & Co. KGaA is a global leader in medical and safety technology, delivering innovative solutions that protect, support, and save lives. Founded in 1889 and headquartered in Lübeck, Germany, the company operates as a subsidiary of Stefan Dräger GmbH. Drägers medical division specializes in advanced systems and devices for critical care environments, including emergency medicine, perioperative care, intensive care, and perinatal medicine. Its product portfolio spans patient monitoring systems, anesthesia machines, medical ventilators, neonatal incubators, phototherapy lights, surgical and examination lights, and medical gas pipeline systems, ensuring comprehensive care in hospitals and healthcare facilities. The company also offers hospital planning and design services, emphasizing efficiency and patient-centric infrastructure.

In the safety sector, Dräger provides cutting-edge technology for personal protection, gas measurement, and risk management. Its solutions cater to industries such as mining, oil and gas, fire departments, police, and disaster response. Products include portable and fixed gas detectors, hazmat suits, respiratory protection, thermal imaging cameras, and safety training systems. Drägers portfolio also extends to alcohol and drug testing, head protection, rescue and escape equipment, and breathing gas supply systems, ensuring safety in hazardous environments. The companys commitment to innovation and reliability has established it as a trusted partner for industries requiring precise and durable safety solutions.

Technically, DRW3 is trading near its SMA20 at 60.85, with a last price of 60.30, indicating a potential downtrend. The SMA50 at 59.13 and SMA200 at 50.44 suggest a narrowing price range. ATR of 2.44 signals moderate volatility. On the fundamental side, with a market cap of 1029.74M EUR, P/E of 9.23, and P/B of 0.75, the stock appears undervalued. The RoE of 8.10% reflects moderate profitability.

Forecast: Based on , the stock may face resistance near 60.85. A break below 59.13 could signal further decline. suggests value at current levels, with P/E and P/B below industry averages, indicating potential long-term upside. Investors may consider a hold or accumulation strategy near support levels, balancing technical weakness with fundamental strength.